| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2018/02/09 | 23:13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04:22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 02:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 02:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 02:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |